C3i Center Inc. Supports the Manufacturing of the First Canadian-Made CAR-T Cell Therapy for the Treatment of Solid Tumours
An innovative treatment for advanced metastatic HER2-positive tumours has been administered to the first patient in a phase I/II clinical trial. The investigational T-cell antigen… Read More »